Definition of Severity and Relapse for Vitiligo

Read full text
Authors: Viktoria Eleftheriadou, Seemal Desai, Jung Min Bae, Stephen Taylor, Jean-Marie Meurant, Marwa Abdallah, Hyun Jeong Ju, Laïla Benzekri, Albert Wolkerstorfer, Markus Böhm, Leihong F. Xiang, Emma Rush
+78 more Iltefat H. Hamzavi, Thierry Passeron, Henry Lim, J. E. Harris, Davinder Parsad, Richard H. Huggins, Alexandre Schneider, Antonios G.A. Kolios, David Rosmarin, Tasneem F. Mohammad, Samia Esmat, Janet Jones, Ameeta Retzer, Julien Seneschal, Maria-Angeliki Gkini, Alia Ahmed, Andrew R. Thompson, Amit G. Pandya, Samantha Cruz Rivera, Fanny C. Kpenou, Khaled Ezzedine, INTERCEPT Study Group and the Global Vitiligo Atlas, Nada Elbuluk, Giovanni Leone, Adrian Mar, Sang Ho Oh, John Ferguson, Somesh Gupta, Naoki Oiso, Noufal Raboobee, Nanja VanGeel, Agustín Alomar, Reinhart Speeckaert, Steven Thng Tien Guan, Tamio Suzuki, Eric Lan, Deepti Ghia, Michelle Rodrigues, A. Bertolotti, Silvia Alberti, Prasad Kumarasinghe, Mahy El-Basyouni, Emily Yiping Gan, Victor Huang, Caio César Silva de Castro, Ju Hee Han, Ajith Cy, Angela Miller, Shahnawaz Towheed, Jennifer Creasor, Cerith S. Waters, Claudia Money, Gill Nightingale, Colin Tait, Justine Simon, Eva Mackay, Angela Eccles, Paul Reade, Janette Kerr, Jane Berry, Maria Reynolds, Shona Wright, Richard Tipping, Rita Kumar, Charles W. Hilsdon, Jeannie Burton, Patricia Whincup, Khan Muhammad, Helen Scott, Juan Tolentino, Alicia Roufs, Robert Hubbard, Justin Hall, Blessing Adamu, Alisha Archibald, Denise Blanks, Aslean Temple, Frederic Dechandal
Cited by: 3
References: 38

Abstract

Importance: There is no international consensus on defining vitiligo severity or relapse. Current measures (such as body surface area) quantify depigmentation but do not fully capture the broader clinical and psychosocial effects of the disease. Objective: To develop internationally agreed-upon definitions and criteria for vitiligo severity and relapse as part of the International Consensus on Definition of Severity and Relapse in Vitiligo study. Evidence Review: This global, mixed-methods consensus study used a multistep approach, including comprehensive literature review, qualitative study, 2 rounds of electronic Delphi surveys, and a final consensus meeting. To ensure adequate diversity and inclusivity and to capture a broad range of experiences, perspectives, social contexts, and representation, a recruitment framework (encompassing variation in age, sex, and skin phototypes) was predefined. Findings: In total, 91 people from 5 continents expressed interest in participating. Experts (dermatologists, trialists, methodologists, nurses, psychologists, journal editors, and researchers) and people with vitiligo from diverse ethnic backgrounds and skin phototypes took part. During the first electronic Delphi survey round, 85 people participated and 81 participated in round 2 (response rate of 95% in each survey round). Consensus was reached that even though measurement of body surface area remains a necessary and adequate starting point for assessing vitiligo severity, this measure alone is insufficient to capture disease burden. The final consensus meeting included 44 participants (response rate of 54%). Twelve criteria for upgrading severity were recommended, encompassing both clinical aspects of vitiligo and its psychosocial effects. The major criteria for vitiligo include spread or active disease, involvement of highly visible or high-impact areas, psychological distress, stigmatization, lack of self-acceptance, and overall burden. The minor criteria for vitiligo include darker skin tones, younger age, involvement of scalp/facial hair, increased risk of sunburn, impact on career or school, and perceived loss of personal or cultural identity. No consensus was reached on the extent of pigment loss. Relapse was defined as loss of pigmentation in previously repigmented lesions (repigmentation had occurred either spontaneously or with treatment). Conclusion and Relevance: This global, mixed-methods consensus study established internationally agreed-upon severity criteria for vitiligo. This consensus aims to bridge the gap between physician assessment and patient experience; improve the relevance and consistency of the severity classification in clinical care, research, and regulatory frameworks; and help close the remaining gaps in the diagnosis and classification of vitiligo.

Fields of Study & Subjects

melanin and skin pigmentation Mast cells and histamine Acne and Rosacea Treatments and Effects

Publication details

Journal / source
JAMA Dermatology
Publisher
American Medical Association (AMA)
Volume
162
Issue
5
Pages
515–515
Publication date
25 March 2026
Language
EN